Life Sciences Archive » August, 2007

Life Sciences - August, 2007

150 articles

• 'Integra': Safe Harbor For Research Tool Patents?
• Appeals Court Reinstates Ephedra Suit
• Pennsylvania Drops K-Dur Antitrust Suit
• Class Certified In McKesson Drug Pricing Case
• Ranbaxy Blocked From Copying Schering's Clarinex
• Abbott Off The Hook In $5.5B J&J Merger Suit
• AGs Strike $16M Deal In Guidant Defibrillator Case
• Gender Bias Suit Morphs Into Massive Class Action
• Whistle-blower Suit Over Pfizer's Lipitor Unsealed
• Sandoz Says An Eli Lilly ADHD Drug Patent Is Invalid
• Northwest Sued Over Cancer Vaccine Claim
• Seroquel Judge Sets Homework For AstraZeneca
• Boston Scientific's Trade Claim Tossed In Ev3 Feud
• Amgen, Roche Battle Heads To Trial
• Women Drop Claims Against Pharmas Over DES
• Boston Scientific Loses Bid To Toss ERISA Suit
• Nixon Peabody
• High Court Rulings Have Limited Antitrust Liability
• Goldman Sachs Worker Admits Insider Trading
• Apotex Defends Declaration In Acular Patent Suit
• Judge Tosses More Plaintiffs From Celebrex Case
• Aredia Patients Push For Dental Monitoring Class
• Celgene Sues Barr Over Generic Thalomid
• Judge Approves Breast Implant Maker's Asset Auction
• FDA To Study Television Drug Ads
• Align Declares Victory In Orthodontic Patent Case
• Judge Throws Novartis Suit Out Of Federal Court
• Trasylol Continues To Cause Heartache For Bayer
• Depo-Provera Case Must Stay In Calif.: MDL Panel
• Lessons From A Hospital Merger Enforcement Action
• Nellson's Creditors Seal $153.5M Buyout Deal
• Abbott Fights Order Allowing Shared Discovery
• Dewey Ballantine Adds IP Litigation Partner
• Aetna, Cigna Prevail In Joint Implant Maker's Suit
• MedPointe Sues Generics Maker Over Allergy Spray
• Novartis Fights Magistrate's Remand Stance
• Dr. Can't Be Deposed In Defective Syringe Suit: Judge
• Court Nixes Bid By Lerach Client In Securities Suit
• MDL Panel Transfers All Clarinex Cases To N.J.
• King & Spalding
• Judge Tosses Some Claims In Stent Suit
• Sales Reps Dismiss Novartis Class Action
• Corrected: Federal Law Shields Drug Giant, Court Says
• Australians Get Priority On HPV Vaccine Patent
• SonoSite Adds Patents To GE Ultrasound Spat
• J&J Fights For Judgment In Drug Pricing Suit
• AstraZeneca Wants 11 Seroquel Cases Axed
• Judge Dismisses Retaliation Case Against Wyeth
• Wholesaler Sues Sanofi-Aventis Over Arthritis Drug
• AstraZeneca Faces Sanctions In Seroquel MDL
• Landmark Seagate Decision Sinks Willfulness Test
• Becton Claims Sterling Compliance, Slams Suits
• Lawyers Antsy As PTO Publishes New Rules
• Walgreens Must Pay Millions Over Prescription Error
• Defendants Push For Mediation In Drug Pricing Suit
• Attorneys Plead For New Class In Fosamax Case
• Judge OKs Common Benefit Fund In Zyprexa Suit
• Bayoil Execs Plead Guilty In Oil-For-Food Scandal
• Wyeth Fights Prempro Plaintiffs' Latest Discovery Bids
• China Stops Imports Of U.S.-Made Pacemakers
• Guidant Fights Plaintiff's Bid To Lift Stay
• Biotech Co. Wants Class Action Tried On Home Turf
• Drug Wholesale Price Plaintiffs Eye Later Judgment
• Medical Equipment Maker Wins One, Loses One
• Backdating Probes Into CVS Caremark Dropped
• Suits Multiply Over C.B. Fleet's Laxative
• PTO Won't Let Lipitor Patent Last Past 2010
• Heart Drug Linked To Pacemaker Need In Women
• Biomet Takes Surgical Screws Suit To Supreme Court
• Court Upholds Ex-Impath President's Conviction
• Human Tissue Lawsuits Flood MDL Case
• Judge Bars Causality Assessments In Accutane MDL
• Teva Appeals Plavix Ruling To Federal Circuit
• Plaintiffs Seek Certification In Pfizer Class Action
• Merck Told To Fork Over Disputed Documents
• Diabetes Drugs To Feature Black Box Warning
• Morrison Foerster
• Latham & Watkins LLP
• More Medtronic Plaintiffs Bow Out Of MDL
• Prexige, Pulled In Australia, Still Viable: Novartis
• Lawmakers Review FDA's Investigation Of J&J Stent
• Pfizer Fights Celebrex Plaintiffs' Bid To Bar Experts
• Google's Court Battle Over Sponsored Links Program
• Mirapex Plaintiffs Haggle Over Bellwether Details
• AstraZeneca Fires Back At Plaintiffs In FLSA Suits
• A Roadmap For The Wary Advertiser
• Regulator Says Pfizer Used Misleading Advertisement
• Aventis Continues Fight Over Generic Allegra
• AstraZeneca Seeks Protective Order In Seroquel MDL
• Novartis Seeks To Fracture Class In Bone Drug Suit
• Fen-Phen Lawyers Await Trial In Jail
• Novartis Sues Ranbaxy Over Top-Selling Diovan
• AWP Defendants Pressure Judge To Rule On Damages
• Applied Medical, Tyco Bury Some Claims
• Wyeth Wants Prempro Records Preserved
• Vioxx Stroke Suits Continue To Pour In
• J&J Resists Bid To Keep Ortho Evra Docs Secret
• Eli Lilly Sues Actavis To Block Generic ADHD Drug
• Baycol Plaintiffs Seek Appeal Of Testimony Exclusion
• Pharmas Spar Over Plant-Based Mood Enhancer
• Regulators Warn Thailand Over Drug Pricing Policy
• Genzyme To Cough Up $64M To Settle Suit
• Breast Implant Maker Eyes September Asset Auction
• Court Nixes Boston Scientific's Bid For Lumen Patent
• Procrit Scrutinized For Safety, Marketing
• CVS Caremark Backs Down From Options Fight
• Warner Chilcott Settles Another Ovcon Suit For $10M
• Ruling Tightens Rein On Securities Fraud Plaintiffs
• Smith & Nephew Sues Over Knee Surgery Patents
• J&J Sues Red Cross Over Cross Trademark
• Court Keeps Alive Medicare Fraud Suit Against Sun
• More Plaintiffs Dumped From Bextra Litigation
• MIT's Claim Construction Prevails In ImClone Suit
• Novartis Fights Bid For Sanctions Over Remand Issue
• Baxter Expands Infusion Pump Recall
• EU Suspends HIV Drug License
• Abbott Wins Unrestricted Use Of Stent Patent
• N.J. Court Decision May Herald A Nationwide Trend
• Firms Vie To Be Lead Counsel In Telik Fraud Case
• House Gives FDA More Funding For Food Safety
• AstraZeneca Whittles Down Seroquel Case
• AstraZeneca Fights Damages In Drug Pricing Suit
• Circuit Denies Access To Unapproved FDA Drugs
• Indian Court Strikes Down Novartis' Patent Fight
• Judge Orders Fen-Phen Attorneys To Repay $62M
• Ruling Tossing 2 Plaintiffs From Guidant MDL Affirmed
• J&J, Merck Appeal Pepcid Invalidity Ruling
• Nucleonics Asks Appellate Court To Reconsider
• Warrick Fires Back Over Drug Pricing Damages
• Judge Overturns Largest Patent Verdict In History
• Are DNA Patent Claims Endangered?
• Reply Memo Turns Abbott Suit More Contentious
• FDA To Use DOD Data In Product Safety Decisions
• Appeals Court Applies Preemption To Medtronic Case
• Abbott Secures Order To Keep Settlement Confidential
• Plaintiffs Propose "Road Map" For Drug Pricing Suit
• Tyco Severs Rochester Antitrust Suit From Others
• Judge Limits Discovery in Prempro MDL
• Federal Circuit Strikes Down D.C. Pharmaceutical Law
• Fund Manager Settles Insider Trading Case With SEC
• PharmaNet Agrees To $28.5M Securities Settlement
• Judge Issues Mixed Ruling In Drug Pricing Suit
• Senators Question OxyContin Deal
• RealNetworks Wins Dismissal On Second Try
• Abbott-LifeScan Deal To Be Kept Secret
• Novartis Unit Hit With Gender Bias Class Action
• Circuit Denies Extension For Depression Patch Patent
• Judge Says British Plaintiffs Must Sue Vioxx At Home
• Discovery Battles Heat Up Over Wyeth's Prempro
• Northwest, Lonza Battle Over Gene Patents